Article Information
History
- August 17, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Athanasios Kousathanas1,*,
- Christopher A. Odhams1,
- James Cook1,
- Yao Hu2,
- Stephan Klee3,
- A. Mesut Erzurumluoglu2,
- Fidel Ramirez2,
- Christoph Mayr3,
- Dennis Schäfer3,
- Lara Beck3,
- Ingrid Christ3,
- Taekyu Lee4,
- James Christopher Tarr4,
- Steven W. Fesik4,
- Boehringer Ingelheim – Global Computational Biology and Digital Sciences,
- James Duboff1,
- Frederik Wirtz-Peitz1,
- Loukas Moutsianas1,
- Matthew A. Brown1,
- Jan Kriegl2,
- Goerge Okafo2,
- Jan N Jensen2,
- Matthew J. Thomas3 and
- Zhihao Ding2,*
- 1Genomics England, London, UK
- 2Global Computational Biology and Digital Sciences (gCBDS), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
- 3Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
- 4Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA
- ↵*Corresponding authors: Athanasios Kousathanas, Athanasios.Kousathanas{at}genomicsengland.co.uk; Zhihao Ding, zhihao.ding{at}boehringer-ingelheim.com
Posted August 17, 2024.
Common and rare variant analyses reveal novel genetic factors underlying Idiopathic Pulmonary Fibrosis and shared aetiology with COVID-19
